Digital Sales Spur J&J Beauty Growth For Strengthening Consumer Business
This article was originally published in The Rose Sheet
Executive Summary
Strong US e-commerce sales for J&J's Neutrogena and Aveeno lines drove 7.8% sales growth for its beauty division in the first quarter. Analysts say the consumer health business is showing signs of a comeback, with worldwide sales up 5.3% on a reported basis, or 1.6% excluding currency-exchange impact.
You may also be interested in...
J&J's Baby, Beauty Sectors Boost Consumer Health Sales Rebound
Johnson’s baby product sales picked up in the third quarter after a rough start as its baby care division sales up 20% in the US to $120m. US consumer health sales grew 6.6% to $1.37bn, also helped by total worldwide beauty sales increasing 6.5% to $1.08bn.
J&J Baby Care Launches Crucial To Second-Half Consumer Business Results
Baby care products sales were a drag on J&J's consumer sector, falling at a reported 7.7% to $456m. US sales particularly were off, down reported21.2% to $89m, and international results were off 3.7% to $367m. Worldwide beauty sales were up a reported 3.1% to $1.11bn, but US sales were down 1.8% to $637m.
J&J Consumer Makes 'Aggressive' Shift In Digital Sales To Drive Growth
When J&J CEO Gorsky says, "We're not just sitting back, we're making aggressive moves in areas such as e-commerce – investments in that shift," his words are music to analysts' ears. J&J has OTC drug and other consumer health brands to drive growth, but it's missing the digital piece, they say.